Why Independent Pharmacies Are Disappearing, And Why That Should Scare You

The Economics That Are Closing Independent Pharmacies

The primary financial mechanism eliminating independent pharmacies is the Pharmacy Benefit Manager reimbursement system we discussed in detail in Category 3.

PBMs, the three largest of which are owned by CVS Health, Cigna, and UnitedHealth Group, set the rates at which pharmacies are reimbursed for filled prescriptions. These rates are set through confidential contracts that pharmacies must accept to participate in insurance networks their patients depend on.

The reimbursement rates offered to independent pharmacies are frequently lower than those offered to chain pharmacies, reflecting the greater negotiating leverage of large chain networks. In many cases independent pharmacies are being reimbursed at rates that fall below the actual cost of acquiring and dispensing the medication.

A pharmacy that is reimbursed less than the cost of the product it dispenses cannot remain financially viable. This is not a failure of the pharmacy’s management or efficiency. It is a structural consequence of a reimbursement system that has been designed, whether intentionally or as a predictable consequence of vertical integration, to favor the pharmacies owned by the same corporate families that control the reimbursement rates.

DIR fees, the post dispensing clawbacks PBMs charge pharmacies months after prescriptions have been filled, add an additional layer of financial unpredictability that makes independent pharmacy business planning genuinely difficult. A pharmacy that fills a prescription in January may not know until April what the net reimbursement for that prescription will be after DIR fee assessment.

What Communities Lose When Their Independent Pharmacy Closes

The loss of an independent pharmacy is not simply the loss of a retail location where medications can be purchased. It is the loss of a clinical relationship and a community health infrastructure that cannot be replicated by a chain location.

The pharmacist relationship. An independent pharmacist who has served a community for ten or twenty years knows their patients, their complete medication histories, their family situations, their chronic conditions, their cognitive status, their ability to manage complex regimens. This accumulated clinical knowledge is not transferable. It does not exist in a chain pharmacy database. When the independent pharmacist closes, that knowledge disappears.

Clinical services. Independent pharmacies are significantly more likely to offer Medication Therapy Management, immunizations, medication synchronization, blister packaging for complex regimens, compounding, and other clinical services that chain pharmacies systematically underprovide because their productivity models prioritize prescription volume over clinical service delivery.

Geographic access. A significant proportion of independent pharmacy closures occur in rural and underserved communities, exactly the communities that most depend on local pharmacy access because transportation to a distant chain location is a genuine barrier. When an independent pharmacy closes in a rural Mississippi county and the nearest chain pharmacy is thirty miles away, patients on chronic medications face a real access crisis that affects medication adherence and health outcomes.

Economic contribution. Independent pharmacies are locally owned businesses that employ local staff, purchase from local suppliers where possible, and reinvest their revenue in the local economy. A chain pharmacy location remits its profits to a corporate parent headquartered elsewhere.

Pharmacy Deserts

The geographic consequence of independent pharmacy closures, particularly in rural areas, is the creation of pharmacy deserts: communities where no pharmacy exists within a reasonable distance.

Research has documented that pharmacy deserts are disproportionately concentrated in low income, rural, and predominantly minority communities. The communities with the greatest barriers to pharmacy access are the same communities with the highest rates of chronic diseases, diabetes, hypertension, heart disease, that most depend on consistent medication access and pharmacist counseling.

A pharmacy desert is a health equity crisis. It is also a predictable downstream consequence of a reimbursement system that makes operating a pharmacy in underserved communities financially untenable.

Why Fairview Is Still Here

Fairview Pharmacy has been operating in Hattiesburg, Mississippi since 1978. We have survived the first wave of chain pharmacy expansion in the 1980s and 1990s, the PBM consolidation of the 2000s, the DIR fee crisis of the 2010s, and the COVID disruptions of the early 2020s.

We are still here because we have never operated under the assumption that prescription volume alone is the measure of a pharmacy’s value. We have always offered clinical services that generate patient loyalty that transcends price. We have always cultivated patient relationships that make the experience of filling a prescription at Fairview meaningfully different from filling it at a chain location.

We are also still here because our patients have chosen to fill their prescriptions here, and that choice, repeated every month by every patient, is the most direct financial expression of the value they place on the independent pharmacy relationship.

Every prescription you fill at an independent pharmacy is a vote for the continued existence of independent pharmacy in your community. That is not a marketing line. It is arithmetic.

What You Can Do

Fill your prescriptions at an independent pharmacy when one is available. Independent pharmacy pricing on generics is frequently competitive with chain pricing, and in many cases better, because independent pharmacies do not have the same corporate overhead structures as chain locations.

Tell your physician you prefer to use an independent pharmacy. Prescribers have some ability to route prescriptions and referrals, and most physicians, when they understand the clinical value of the independent pharmacy relationship, are supportive of patients who want to maintain it.

Advocate for PBM reform. State and federal PBM transparency and reimbursement reform legislation directly affects the financial viability of independent pharmacy. Patients who understand the issue are the most credible advocates for the reforms that would level the playing field.

This article is for general information only and is not a substitute for personalized medical advice. Before starting or changing any medication, including over the counter products and supplements, talk with your pharmacist or physician about your specific situation.